Honolulu: Biomarker Profiles That Spell Trouble for ‘Normals’?
Scientists have drafted a new set of diagnostic research criteria redefining AD as a condition that develops decades prior to obvious symptoms...
6397 RESULTS
Sort By:
Scientists have drafted a new set of diagnostic research criteria redefining AD as a condition that develops decades prior to obvious symptoms...
Researchers are sliding electrodes into the brains of people with Alzheimer disease, hoping to awaken memories and stave off disease-induced forgetfulness...
Beyond the lab mouse, AD researchers may have access to a growing repertoire of brainier, brawnier species for their in vivo studies...
ALS is tragic when it hits in late or middle age, but a rare juvenile form of the disease is all the more devastating...
Antibodies to synthetic Aβ oligomers, or “globulomers,” improve cognition in a mouse model of Alzheimer disease...
Paralysis is not always a bad thing—during sleep, it is essential to prevent us from acting out our dreams...
A comprehensive proposal of new diagnostic criteria marked a highlight at the International Conference on Alzheimer’s Disease...
Three workgroups of clinicians from the U.S. and Europe offered new guidelines for the diagnosis of AD...
Three groups presented results of their ongoing effort to incorporate scientific advances of the past quarter-century into a revision of the current diagnostic AD criteria...
New data from several independent studies suggest using neural stem cells to patch wide swaths of failing brain circuitry in AD may have a fighting chance...
World Alzheimer Conference 2000: De la Monte Receives Alzheimer Medal World Alzheimer Conference 2000: Symposium on ApoE World Alzheimer Conference 2000: Symposium on Therapeutic Approaches World Alzheimer Conference 2000: Drosophilae in the Emulsifier Wo
TDP-43 was an unknown in the neurodegeneration field until four years ago, but since then has received plenty of attention...
Intranasal insulin seemed to improve certain measures of cognition and daily function, as well as biomarker profiles, in patients with MCI or early AD...
For the first time, a paper details a molecular mechanism that links tau to Aβ toxicity at the synapse...
If β amyloid is indeed an early driver of Alzheimer disease pathogenesis, AD patients presumably churn out the peptide too quickly, clear it too slowly, or both...